BIOMAT Database Logo BIOMAT Database Logo

Viability of Mycobacterium leprae pretreated with rifampicin. 1976

Y Matsuo, and S Utsunomiya

UI MeSH Term Description Entries
D009166 Mycobacterium leprae A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

Y Matsuo, and S Utsunomiya
Correlation of morphology with viability of Mycobacterium leprae.
October 1976, Leprosy in India,
Y Matsuo, and S Utsunomiya
Viability of blood-borne Mycobacterium leprae.
September 1974, The Journal of infectious diseases,
Y Matsuo, and S Utsunomiya
Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
January 1976, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
Y Matsuo, and S Utsunomiya
Ansamycin activity against rifampicin-resistant Mycobacterium leprae.
May 1984, Lancet (London, England),
Y Matsuo, and S Utsunomiya
Correlation viability/morphology in Mycobacterium leprae.
January 1984, Acta leprologica,
Y Matsuo, and S Utsunomiya
Rapid detection of resistance to rifampicin in Mycobacterium leprae.
December 2000, Leprosy review,
Y Matsuo, and S Utsunomiya
The effect of rifampicin on Mycobacterium leprae in mice.
January 1974, Japanese journal of microbiology,
Y Matsuo, and S Utsunomiya
Viability of Mycobacterium leprae after multiplication in mice.
November 1980, Infection and immunity,
Y Matsuo, and S Utsunomiya
Viability of Mycobacterium leprae outside the human body.
December 1977, Leprosy review,
Y Matsuo, and S Utsunomiya
Rifampicin-resistant strains of Mycobacterium leprae may have reduced virulence.
January 1988, Journal of medical microbiology,
Copied contents to your clipboard!